| Name | Title | Contact Details |
|---|---|---|
Haley Burrow |
Director, People & Culture Service & Experience and Talent Acquisition | Profile |
Amy Scherer |
AVP, Finance | Profile |
Carrie Kufta |
Vice President, Customer Engagement | Profile |
Alissa Weiher |
Director of Talent Development | Profile |
Jarvik Heart is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bodypoint is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pinnacle Products Inc is a Lakeville, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CTI Molecular Imaging Inc is a Knoxville, TN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.